Drug Type Antibody toxin conjugate |
Synonyms- |
Target |
Action modulators |
Mechanism CD47 modulators(Cluster of differentiation 47 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | United States | 25 Feb 2025 | |
Melanoma | Preclinical | United States | 25 Feb 2025 |